| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/08/2005 | US6852715 Formula (1) wherein R1 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon atoms; and R2 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon |
| 02/08/2005 | US6852704 Compositions and methods for reverse gene therapy, wherein a gene therapy vector encoding a gene product (e.g. a protein) which is usually only expressed in cells of an abnormal tissue is delivered to a cell of an animal afflicted with a disease |
| 02/08/2005 | US6852703 A vector comprising a nucleotide sequence of interest ("NOI") encoding a product of interest ("POI") is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI |
| 02/08/2005 | US6852700 Colostrinin, and uses thereof |
| 02/08/2005 | US6852537 Transgenic circulating endothelial cells |
| 02/08/2005 | US6852533 For making vectors for gene therapy |
| 02/08/2005 | US6852532 Isolating human nervous system tissue from fetal tissue; obtain human fetal cells, culture, immunodeplete, isolate nervous system tissue |
| 02/08/2005 | US6852528 Human and mouse uroplakin II gene transcriptional regulatory elements |
| 02/08/2005 | US6852522 Methods and interferon deficient substrates for the propagation of viruses |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852509 Anti-P53 single-chain antibody fragments and their uses |
| 02/08/2005 | US6852331 Embedding cells in three-dimensional structure |
| 02/08/2005 | US6852321 Lectin-derived progenitor cell preservation factor and methods of use |
| 02/08/2005 | CA2223130C Method using oxygen removal for extending the useful shelf-life of refrigerated red blood cells |
| 02/08/2005 | CA2184183C Inhibin compositions and methods of use thereof |
| 02/03/2005 | WO2005010172A2 Aligned scaffolds for improved myocardial regeneration |
| 02/03/2005 | WO2005010149A2 Subgroup b adenoviral vectors for treating disease |
| 02/03/2005 | WO2005009498A2 Decellularized bone marrow extracellular matrix |
| 02/03/2005 | WO2005009497A1 Decellularized extracellular matrix of conditioned body tissues and uses thereof |
| 02/03/2005 | WO2005009466A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using alloreactive natural killer cells |
| 02/03/2005 | WO2005009465A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |
| 02/03/2005 | WO2005009460A2 Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer |
| 02/03/2005 | WO2005009451A1 Bacteriophage-containing therapeutic agents |
| 02/03/2005 | WO2005009450A2 Use of botulinum toxin for producing drug for preventing or treating final phase of lung troubles |
| 02/03/2005 | WO2005009391A2 Antibiotic compound |
| 02/03/2005 | WO2004105912A3 Method of producing eggshell powder |
| 02/03/2005 | WO2004100773A3 Diagnostic and therapeutic treatments related to mitochondrial disorders |
| 02/03/2005 | WO2004045550A3 Immunization with porphyromonas gingivalis protects against heart disease |
| 02/03/2005 | WO2003079967A3 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 02/03/2005 | US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 02/03/2005 | US20050026866 Detecting or treating mammalian tumor cells; tissue-targeted therapy; genetic engineered Bordetella pertussis; biodrugs |
| 02/03/2005 | US20050026854 Antibody is used to prevent, or treat of graft versus host disease; Antibody dependent cellular cytotoxicity; anti-sense nucleic acid; graft-versus-tumor activity and immunotherapy |
| 02/03/2005 | US20050026816 modified via polyoxyethylene glycol; improved stability to autooxidation; blood substitutes |
| 02/03/2005 | US20050026289 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/03/2005 | US20050026283 Using electric field modification to transfer components across cell barriers; organelle transfer; in vitro fertility |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |
| 02/03/2005 | US20050026220 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/03/2005 | US20050026136 Hypoxia-mediated neurogenesis |
| 02/03/2005 | US20050025838 Conditioned compositions for tissue restoration |
| 02/03/2005 | US20050025837 Powders for use as dietary supplement for immunostimulant, wound healing, inhibiting infection |
| 02/03/2005 | US20050025836 Such as cows or sheep having leucosis, substance is obtained from the lipid-free blood plasma fraction of a pregnant animal |
| 02/03/2005 | US20050025755 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 02/03/2005 | US20050025749 Grafting heart tissue; closure of heart defect |
| 02/03/2005 | US20050025748 Delivery of compounds with rehydrated blood cells |
| 02/03/2005 | US20050025747 Containing a priming and boosting composition, each with a non-replicating viral vector, with at least one of them being derived from a fowlpox virus; malaria, tuberculosis |
| 02/03/2005 | DE10362002A1 Adulte pluripotente Stammzellen Adult pluripotent stem cells |
| 02/03/2005 | DE10329324A1 Pharmarzeutischer Schlankmacher Pharmarzeutischer slimming |
| 02/03/2005 | DE10328669A1 Plasmidfreier Klon des E. coli Stammes DSM 6601 Plasmid-free clone of E. coli strain DSM 6601 |
| 02/03/2005 | CA2533352A1 Bacteriophage-containing therapeutic agents |
| 02/03/2005 | CA2532802A1 Antibiotic compound isolated from streptomyces sp |
| 02/03/2005 | CA2532547A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |
| 02/03/2005 | CA2527369A1 Subgroup b adenoviral vectors for treating disease |
| 02/02/2005 | EP1502947A1 Use of proteins from whey for the production of microorganisms |
| 02/02/2005 | EP1502601A1 Use of neurotoxin therapy for treatment of urinary retention |
| 02/02/2005 | EP1502600A1 Use of botulinum toxin for treating smooth muscle disorders |
| 02/02/2005 | EP1501921A1 Improved viral purification methods |
| 02/02/2005 | EP1501918A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance |
| 02/02/2005 | EP1501860A2 Modulation of heat-shock-protein-based immunotherapies |
| 02/02/2005 | EP1501852A2 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 02/02/2005 | EP1501537A1 Mannose binding lectin and uses thereof |
| 02/02/2005 | EP1501465A2 Vectors having both isoforms of beta-hexosaminidase |
| 02/02/2005 | EP1221490B1 Recombinant adenoviral vectors and their utilization in the treatment of liver cirrhosis |
| 02/02/2005 | EP1187909B1 Fabrication of threedimensional vascularized tissue using microfabricated two-dimensional molds |
| 02/02/2005 | EP0966534B1 Compositions and methods for elimination of unwanted cells |
| 02/02/2005 | EP0868505B1 In vitro chondrogenic induction of human mesenchymal stem cells |
| 02/02/2005 | EP0851769B1 Gene therapy using ovine adenoviral vectors |
| 02/02/2005 | EP0832227B1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 02/02/2005 | EP0757557B1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | CN1575340A Compositions and methods for treating neurodegenerative diseases |
| 02/02/2005 | CN1575190A Bag system for the cryopreservation of body fluids |
| 02/02/2005 | CN1575133A Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 02/02/2005 | CN1572322A Attenuated live neospora vaccine |
| 02/02/2005 | CN1572153A Biological process for the production of a food product comprising heme-iron and food product obtained with said process |
| 02/02/2005 | CN1187453C Cell lines for propagation of mutated herpes viruses |
| 02/02/2005 | CN1187442C Method for transferring antigens to dendritic cells |
| 02/02/2005 | CN1187095C Encapsulated cells capable of producing viral particles |
| 02/02/2005 | CN1187088C Chimeric flavirirus vaccines |
| 02/02/2005 | CN1187087C Application of Batroxobin in preparing medicine for preventing and treating deficient blood-reperfusion disturbance |
| 02/02/2005 | CN1187081C Compound Chinese medicine for treating extensive cancer |
| 02/02/2005 | CN1187079C Auxiliary medicine for cancer and preparation thereof |
| 02/02/2005 | CN1187078C Chinese medicine decoction for curing fatty liver |
| 02/02/2005 | CN1187071C Liver cancer treating medicine and its preparation method |
| 02/02/2005 | CN1187070C Suppository for treating piles and other anorectal diseases and its preparation method |
| 02/02/2005 | CN1187068C Health-care product for preventing and curing cancer |
| 02/02/2005 | CN1187067C Healht-care products with function of strenthening spleen and stomach, delaying sanility and promoting intelligence development and preparation method thereof |
| 02/02/2005 | CN1187062C Chinese medicine preparation for curing hematopathy |
| 02/02/2005 | CN1187060C Extracts of shark cartilage, its preparation method and usage |
| 02/02/2005 | CN1187059C Composition for stimulation melanin synthetic and preparing method thereof |
| 02/02/2005 | CN1187058C Stem cell medicine for repairing damage of central nerve and its preparing process |
| 02/02/2005 | CN1187057C Trivalent cerium carried rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof |
| 02/02/2005 | CN1187043C Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 02/01/2005 | US6849651 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 02/01/2005 | US6849594 An enzyme-linked immunosorbent assay kit comprising a gene expressed proteins from culturing the cells; for repairing or producing cartilage implants |
| 02/01/2005 | US6849454 Highly efficient gene transfer into human repopulating stem cells by RD114 pseudotyped retroviral vector particles |
| 02/01/2005 | US6849452 Bringing an enriched population of resting NK cells into contact with mature or triggered dendritic cells in vitro or ex vivo, under conditions allowing activation of such resting NK cells by mature or triggered cells |
| 02/01/2005 | US6849451 Hybrid cells |
| 02/01/2005 | US6849446 Genetic engineering |
| 02/01/2005 | US6849438 Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1) |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |